Figure 5From: Inhibition of mTORC1 inhibits lytic replication of Epstein-Barr virus in a cell-type specific mannerRapamycin treatment does not alter EBV-positive cell viability, but does decrease cell proliferation. Raji, EBfaV-GFP, and AGS-BDneo cells were left untreated or treated with 5 nM rapamycin for 24Â hr prior to induction of lytic replication, as indicated. 24Â hr later the viability of cells and cell density were determined by flow cytometry. The percentage of viable cells is presented in A, the cell density (total cells/ml) is presented in B.Back to article page